Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Generini

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Rheumatology|February 24, 2001
Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritisG Simonini, M Matucci Cerinic, R Cimaz, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 1999
Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosusF Falcini, C Azzari, V A Gelli, et al.
Clinical and Experimental Rheumatology|November 1, 1996
Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structureS Lori, M Matucci-Cerinic, R Casale, et al.
The Journal of Rheumatology|October 1, 1996
Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levelsF Falcini, M M Cerinic, M Ermini, et al.
Annals of the Rheumatic Diseases|October 1, 1996
Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritisF Falcini, M Matucci Cerinic, A Lombardi, et al.
Pathologica|August 1, 1994
[Expression of p53 in the skin in systemic sclerosis. Immunohistochemical study of 8 cases]A Pignone, A Calzolari, M M Cerinic, et al.
Molecular and Cellular Biochemistry|August 17, 1999
Oxidative stress in Systemic SclerosisG Simonini, M M Cerinic, S Generini, et al.
Toxicology|January 13, 2001
Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosisG Simonini, A Pignone, S Generini, et al.
Rheumatology (Oxford, England)|February 25, 2005
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosisL Ibba Manneschi, A Del Rosso, A F Milia, et al.
Arthritis and Rheumatism|November 1, 1995
Somatostatin-induced modulation of inflammation in experimental arthritisM Matucci-Cerinic, F Borrelli, S Generini, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Rheumatology|February 24, 2001
Evidence for immune activation against oxidized lipoproteins in inactive phases of juvenile chronic arthritisG Simonini, M Matucci Cerinic, R Cimaz, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 1999
Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosusF Falcini, C Azzari, V A Gelli, et al.
Clinical and Experimental Rheumatology|November 1, 1996
Peripheral nervous system involvement in systemic sclerosis: the median nerve as target structureS Lori, M Matucci-Cerinic, R Casale, et al.
The Journal of Rheumatology|October 1, 1996
Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levelsF Falcini, M M Cerinic, M Ermini, et al.
Annals of the Rheumatic Diseases|October 1, 1996
Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritisF Falcini, M Matucci Cerinic, A Lombardi, et al.
Pathologica|August 1, 1994
[Expression of p53 in the skin in systemic sclerosis. Immunohistochemical study of 8 cases]A Pignone, A Calzolari, M M Cerinic, et al.
Molecular and Cellular Biochemistry|August 17, 1999
Oxidative stress in Systemic SclerosisG Simonini, M M Cerinic, S Generini, et al.
Toxicology|January 13, 2001
Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosisG Simonini, A Pignone, S Generini, et al.
Rheumatology (Oxford, England)|February 25, 2005
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosisL Ibba Manneschi, A Del Rosso, A F Milia, et al.
Arthritis and Rheumatism|November 1, 1995
Somatostatin-induced modulation of inflammation in experimental arthritisM Matucci-Cerinic, F Borrelli, S Generini, et al.
Pageof 5